Crossmark

Advances in targeting ‘undruggable’ transcription factors with small molecules

Crossref DOI link: https://doi.org/10.1038/s41573-021-00199-0

Published Online: 2021-05-18

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Henley, Madeleine J. https://orcid.org/0000-0002-0709-6186
Koehler, Angela N. https://orcid.org/0000-0001-6980-5534
License Information

Text and Data Mining valid from 2021-05-18

Version of Record valid from 2021-05-18
More Information

Article History

Accepted: 30 March 2021

First Online: 18 May 2021

Competing interests

: A.N.K. is a founder of Kronos Bio and is both a shareholder and a member of the Scientific Advisory Board.